{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:06:12Z","timestamp":1789031172917,"version":"build-2803163510"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06193-0","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:00:47Z","timestamp":1789023647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mesenchymal Stem Cell\u2013Derived Exosomes for Alzheimer\u2019s Disease: Mechanisms, Preclinical Evidence, and Translational Challenges"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9826-3137","authenticated-orcid":false,"given":"Duc-Hiep","family":"Bach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van T.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Liem","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"6193_CR1","unstructured":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 (2022\u00a0) Lancet Public Health\u00a0\u00a07(2):e105-e125"},{"issue":"3","key":"6193_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.14283\/jpad.2021.23","volume":"8","author":"AP Porsteinsson","year":"2021","unstructured":"Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I (2021) Diagnosis of early Alzheimer\u2019s disease: clinical practice in 2021. J Prev Alzheimers Dis 8(3):371\u2013386","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"6193_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-021-00465-0","volume":"16","author":"MM Rahman","year":"2021","unstructured":"Rahman MM, Lendel C (2021) Extracellular protein components of amyloid plaques and their roles in Alzheimer\u2019s disease pathology. Mol Neurodegener 16(1):59","journal-title":"Mol Neurodegener"},{"issue":"1","key":"6193_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14(1):32","journal-title":"Mol Neurodegener"},{"issue":"1","key":"6193_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W (2023) Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther 8(1):248","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"6193_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L (2024) Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther 9(1):211","journal-title":"Signal Transduct Target Ther"},{"issue":"14","key":"6193_CR7","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa013128","volume":"348","author":"B Reisberg","year":"2003","unstructured":"Reisberg B, Doody R, St\u00f6ffler A, Schmitt F, Ferris S, M\u00f6bius HJ (2003) Memantine in moderate-to-severe Alzheimer\u2019s disease. N Engl J Med 348(14):1333\u20131341","journal-title":"N Engl J Med"},{"key":"6193_CR8","doi-asserted-by":"crossref","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D et al (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388(1):9\u201321","DOI":"10.1056\/NEJMoa2212948"},{"key":"6193_CR9","doi-asserted-by":"crossref","unstructured":"Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K et al (2023) Two phase 3 trials of gantenerumab in early Alzheimer\u2019s disease. N Engl J Med 389(20):1862\u20131876","DOI":"10.1056\/NEJMoa2304430"},{"key":"6193_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104511","author":"SJ Andrews","year":"2023","unstructured":"Andrews SJ, Renton AE, Fulton-Howard B, Podlesny-Drabiniok A, Marcora E, Goate AM (2023) The complex genetic architecture of Alzheimer\u2019s disease: novel insights and future directions. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104511","journal-title":"EBioMedicine"},{"issue":"3","key":"6193_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.14283\/jpad.2021.15","volume":"8","author":"XX Zhang","year":"2021","unstructured":"Zhang XX, Tian Y, Wang ZT, Ma YH, Tan L, Yu J-T (2021) The epidemiology of Alzheimer\u2019s disease modifiable risk factors and prevention. J Prev Alzheimers Dis 8(3):313\u2013321","journal-title":"J Prev Alzheimers Dis"},{"key":"6193_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbscr.2026.100145","volume":"20","author":"DH Bach","year":"2026","unstructured":"Bach DH, Nguyen TL (2026) Alzheimer\u2019s disease as a systems-level timing disorder: circadian disruption of glial immunometabolism, brain clearance, and therapeutic responsiveness. Neurobiol Sleep Circadian Rhythms 20:100145","journal-title":"Neurobiol Sleep Circadian Rhythms"},{"key":"6193_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-026-01691-0","author":"DH Bach","year":"2026","unstructured":"Bach DH, Nguyen TL (2026) Immunometabolism reframes Alzheimer\u2019s disease: from systemic dysmetabolism to glial rewiring. Cell Mol Neurobiol. https:\/\/doi.org\/10.1007\/s10571-026-01691-0","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"6193_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56690-4","volume":"16","author":"JL Cummings","year":"2025","unstructured":"Cummings JL, Zhou Y, Van Stone A, Cammann D, Tonegawa-Kuji R, Fonseca J, Cheng F (2025) Drug repurposing for Alzheimer\u2019s disease and other neurodegenerative disorders. Nat Commun 16(1):1755","journal-title":"Nat Commun"},{"key":"6193_CR15","doi-asserted-by":"crossref","unstructured":"Bregman N, Nathan T, Shir D, Omer N, Levy MH, David AB, Aizenstien O, Lotan E et al (2025) Lecanemab in clinical practice: real-world outcomes in early Alzheimer\u2019s disease. Alzheimers Res Ther 17(1):119","DOI":"10.1186\/s13195-025-01763-1"},{"issue":"1","key":"6193_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13195-024-01441-8","volume":"16","author":"LS Honig","year":"2024","unstructured":"Honig LS, Sabbagh MN, van Dyck CH, Sperling RA, Hersch S, Matta A, Giorgi L, Gee M et al (2024) Updated safety results from phase 3 lecanemab study in early Alzheimer\u2019s disease. Alzheimer\u2019s Research & Therapy 16(1):105","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"6193_CR17","doi-asserted-by":"crossref","unstructured":"Chen C, Katayama S, Lee J-H, Lee J-Y, Nakagawa M, Torii K, Ogawa T, Dash A et al (2025) Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer\u2019s disease. J Prev Alzheimers Dis 12(5):100160","DOI":"10.1016\/j.tjpad.2025.100160"},{"key":"6193_CR18","doi-asserted-by":"crossref","unstructured":"Zhang J, Xiang L, Cai X, Geng Y, Wu Y, Shi J, Zhang H, Hu X et al (2026) 3D-MSCs apoptotic bodies-integrated conductive hydrogel mitigates spinal cord injury via immunoregulation and alleviating neuronal pyroptosis. Bioact Mater 60:704\u2013723","DOI":"10.1016\/j.bioactmat.2026.01.043"},{"key":"6193_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-026-01720-y","author":"DH Bach","year":"2026","unstructured":"Bach DH, Van Giang B, Nguyen TL (2026) Cell therapy for spinal cord injury: mechanistic insights and translational challenges. Cell Mol Neurobiol. https:\/\/doi.org\/10.1007\/s10571-026-01720-y","journal-title":"Cell Mol Neurobiol"},{"key":"6193_CR20","doi-asserted-by":"crossref","unstructured":"Mitchell R, Mellows B, Sheard J, Antonioli M, Kretz O, Chambers D, Zeuner M-T, Tomkins JE et al (2019) Secretome of adipose-derived mesenchymal stem cells promotes skeletal muscle regeneration through synergistic action of extracellular vesicle cargo and soluble proteins. Stem Cell Res Ther 10(1):116","DOI":"10.1186\/s13287-019-1213-1"},{"issue":"7","key":"6193_CR21","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.spinee.2022.01.012","volume":"22","author":"E Gonz\u00e1lez-Cubero","year":"2022","unstructured":"Gonz\u00e1lez-Cubero E, Gonz\u00e1lez-Fern\u00e1ndez ML, Olivera ER, Villar-Su\u00e1rez V (2022) Extracellular vesicle and soluble fractions of adipose tissue-derived mesenchymal stem cells secretome induce inflammatory cytokines modulation in an in vitro model of discogenic pain. Spine J 22(7):1222\u20131234","journal-title":"Spine J"},{"key":"6193_CR22","doi-asserted-by":"crossref","unstructured":"Yari H, Mikhailova MV, Mardasi M, Jafarzadehgharehziaaddin M, Shahrokh S, Thangavelu L, Ahmadi H, Shomali N et al (2022) Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach. Stem Cell Res Ther 13(1):423","DOI":"10.1186\/s13287-022-03122-5"},{"issue":"4","key":"6193_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41419-020-2490-4","volume":"11","author":"H Wei","year":"2020","unstructured":"Wei H, Xu Y, Chen Q, Chen H, Zhu X, Li Y (2020) Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis. Cell Death Dis 11(4):290","journal-title":"Cell Death Dis"},{"issue":"1","key":"6193_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41392-023-01704-0","volume":"9","author":"F Tan","year":"2024","unstructured":"Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J (2024) Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther 9(1):17","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"6193_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E (2016) The cellular phase of Alzheimer\u2019s disease. Cell 164(4):603\u2013615","journal-title":"Cell"},{"key":"6193_CR26","doi-asserted-by":"crossref","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388\u2013405","DOI":"10.1016\/S1474-4422(15)70016-5"},{"issue":"3","key":"6193_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14(3):133\u2013150","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"6193_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, Ch\u00e9telat G, Holtzman DM, Hyman BT, Nixon RA, Jones DT (2021) Alzheimer disease. Nat Rev Dis Primers 7(1):33","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"6193_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12951-025-03352-8","volume":"23","author":"S Mehdizadeh","year":"2025","unstructured":"Mehdizadeh S, Mamaghani M, Hassanikia S, Pilehvar Y, Ertas YN (2025) Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies. J Nanobiotechnol 23(1):329","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"6193_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ijc.30669","volume":"141","author":"D-H Bach","year":"2017","unstructured":"Bach D-H, Hong J-Y, Park HJ, Lee SK (2017) The role of exosomes and miRNAs in drug-resistance of cancer cells. Int J Cancer 141(2):220\u2013230","journal-title":"Int J Cancer"},{"issue":"1","key":"6193_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s12951-025-03528-2","volume":"23","author":"N Sanadgol","year":"2025","unstructured":"Sanadgol N, Abedi M, Hashemzaei M, Kamran Z, Khalseh R, Beyer C, Voelz C (2025) Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challenges. J Nanobiotechnol 23(1):453","journal-title":"J Nanobiotechnol"},{"key":"6193_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00811","volume":"12","author":"AM Zagrean","year":"2018","unstructured":"Zagrean AM, Hermann DM, Opris I, Zagrean L, Popa-Wagner A (2018) Multicellular crosstalk between exosomes and the neurovascular unit after cerebral ischemia. Therapeutic implications. Front Neurosci 12:811","journal-title":"Front Neurosci"},{"issue":"1","key":"6193_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","volume":"19","author":"S Gurung","year":"2021","unstructured":"Gurung S, Perocheau D, Touramanidou L, Baruteau J (2021) The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal 19(1):47","journal-title":"Cell Commun Signal"},{"issue":"1","key":"6193_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42485-4","volume":"13","author":"MI Khan","year":"2023","unstructured":"Khan MI, Jeong ES, Khan MZ, Shin JH, Kim JD (2023) Stem cells-derived exosomes alleviate neurodegeneration and Alzheimer\u2019s pathogenesis by ameliorating neuroinflamation, and regulating the associated molecular pathways. Sci Rep 13(1):15731","journal-title":"Sci Rep"},{"issue":"1","key":"6193_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13195-020-00670-x","volume":"12","author":"M Guo","year":"2020","unstructured":"Guo M, Yin Z, Chen F, Lei P (2020) Mesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer\u2019s disease. Alzheimers Res Ther 12(1):109","journal-title":"Alzheimers Res Ther"},{"key":"6193_CR36","doi-asserted-by":"crossref","unstructured":"Yin T, Liu Y, Ji W, Zhuang J, Chen X, Gong B, Chu J, Liang W et al (2023) Engineered mesenchymal stem cell-derived extracellular vesicles: a state-of-the-art multifunctional weapon against Alzheimer\u2019s disease. Theranostics 13(4):1264\u20131285","DOI":"10.7150\/thno.81860"},{"issue":"13","key":"6193_CR37","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.febslet.2015.04.036","volume":"589","author":"T Janas","year":"2015","unstructured":"Janas T, Janas MM, Sapo\u0144 K, Janas T (2015) Mechanisms of RNA loading into exosomes. FEBS Lett 589(13):1391\u20131398","journal-title":"FEBS Lett"},{"issue":"4","key":"6193_CR38","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","volume":"56","author":"YJ Lee","year":"2024","unstructured":"Lee YJ, Shin KJ, Chae YC (2024) Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer. Exp Mol Med 56(4):877\u2013889","journal-title":"Exp Mol Med"},{"issue":"1","key":"6193_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41398-024-03075-8","volume":"14","author":"Y-B Li","year":"2024","unstructured":"Li Y-B, Fu Q, Guo M, Du Y, Chen Y, Cheng Y (2024) MicroRNAs: pioneering regulators in Alzheimer\u2019s disease pathogenesis, diagnosis, and therapy. Transl Psychiatry 14(1):367","journal-title":"Transl Psychiatry"},{"key":"6193_CR40","doi-asserted-by":"crossref","unstructured":"Wang H, Moyano AL, Ma Z, Deng Y, Lin Y, Zhao C, Zhang L, Jiang M et al (2017) MiR-219 cooperates with miR-338 in myelination and promotes myelin repair in the CNS. Dev Cell 40(6):566-582.e565","DOI":"10.1016\/j.devcel.2017.03.001"},{"key":"6193_CR41","doi-asserted-by":"publisher","unstructured":"Garcia G, Pinto S, Ferreira S, Lopes D, Serrador MJ, Fernandes A, Vaz AR, Mendon\u00e7a A et al (2022) Emerging role of miR-21-5p in neuron-glia dysregulation and exosome transfer using multiple models of Alzheimer\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/cells11213377","DOI":"10.3390\/cells11213377"},{"key":"6193_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.842288","volume":"15","author":"X Bai","year":"2022","unstructured":"Bai X, Bian Z (2022) MicroRNA-21 is a versatile regulator and potential treatment target in central nervous system disorders. Front Mol Neurosci 15:842288","journal-title":"Front Mol Neurosci"},{"key":"6193_CR43","doi-asserted-by":"crossref","unstructured":"Haqqani AS, B\u00e9langer K, Stanimirovic DB (2024) Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria. Front Drug Deliv volume 4","DOI":"10.3389\/fddev.2024.1360302"},{"issue":"1","key":"6193_CR44","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12951-025-03352-8","volume":"23","author":"S Mehdizadeh","year":"2025","unstructured":"Mehdizadeh S, Mamaghani M, Hassanikia S, Pilehvar Y, Ertas YN (2025) Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies. J Nanobiotechnology 23(1):329","journal-title":"J Nanobiotechnology"},{"issue":"2","key":"6193_CR45","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1021\/acsnano.0c09873","volume":"15","author":"E L\u00e1zaro-Ib\u00e1\u00f1ez","year":"2021","unstructured":"L\u00e1zaro-Ib\u00e1\u00f1ez E, Faruqu FN, Saleh AF, Silva AM, Tzu-Wen Wang J, Rak J, Al-Jamal KT, Dekker N (2021) Selection of fluorescent, bioluminescent, and radioactive tracers to accurately reflect extracellular vesicle biodistribution in vivo. ACS Nano 15(2):3212\u20133227","journal-title":"ACS Nano"},{"key":"6193_CR46","doi-asserted-by":"crossref","unstructured":"Driedonks T, Jiang L, Carlson B, Han Z, Liu G, Queen SE, Shirk EN, Gololobova O et al (2022) Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrina. Journal of Extracellular Biology 1(10):e59","DOI":"10.1002\/jex2.59"},{"issue":"1","key":"6193_CR47","doi-asserted-by":"publisher","first-page":"26316","DOI":"10.3402\/jev.v4.26316","volume":"4","author":"OPB Wiklander","year":"2015","unstructured":"Wiklander OPB, Nordin JZ, O\u2019Loughlin A, Gustafsson Y, Corso G, M\u00e4ger I, Vader P, Lee Y et al (2015) Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. Journal of Extracellular Vesicles 4(1):26316","journal-title":"Journal of Extracellular Vesicles"},{"key":"6193_CR48","doi-asserted-by":"crossref","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, Sepehrband F, Nelson AR et al (2019) Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med 25(2):270\u2013276","DOI":"10.1038\/s41591-018-0297-y"},{"key":"6193_CR49","doi-asserted-by":"crossref","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E et al (2020) APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature 581(7806):71\u201376","DOI":"10.1038\/s41586-020-2247-3"},{"key":"6193_CR50","doi-asserted-by":"crossref","unstructured":"Cui GH, Guo HD, Li H, Zhai Y, Gong ZB, Wu J, Liu JS, Dong YR et al (2019) RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer\u2019s disease. Immun Ageing 16:10","DOI":"10.1186\/s12979-019-0150-2"},{"issue":"6","key":"6193_CR51","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.4103\/1673-5374.385875","volume":"19","author":"S Gotoh","year":"2024","unstructured":"Gotoh S, Kawabori M, Fujimura M (2024) Intranasal administration of stem cell-derived exosomes for central nervous system diseases. Neural Regen Res 19(6):1249\u20131255","journal-title":"Neural Regen Res"},{"issue":"1","key":"6193_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10571-024-01460-x","volume":"44","author":"Y Ge","year":"2024","unstructured":"Ge Y, Wu J, Zhang L, Huang N, Luo Y (2024) A new strategy for the regulation of neuroinflammation: exosomes derived from mesenchymal stem cells. Cell Mol Neurobiol 44(1):24","journal-title":"Cell Mol Neurobiol"},{"key":"6193_CR53","doi-asserted-by":"crossref","unstructured":"Xian P, Hei Y, Wang R, Wang T, Yang J, Li J, Di Z, Liu Z et al (2019) Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice. Theranostics 9(20):5956\u20135975","DOI":"10.7150\/thno.33872"},{"issue":"6","key":"6193_CR54","doi-asserted-by":"publisher","first-page":"144","DOI":"10.31083\/j.jin2206144","volume":"22","author":"W Huang","year":"2023","unstructured":"Huang W, Fan Y, Jiang C, Jiao J, Ji W, Huang H, Shao J (2023) Marrow mesenchymal stem cell-derived exosomes upregulate astrocytic glutamate transporter-1 expression via miR-124\/mTOR pathway against oxygen-glucose deprivation\/reperfusion injury. J Integr Neurosci 22(6):144","journal-title":"J Integr Neurosci"},{"key":"6193_CR55","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2147\/IJN.S289914","volume":"16","author":"K Liu","year":"2021","unstructured":"Liu K, Cai GL, Zhuang Z, Pei SY, Xu SN, Wang YN, Wang H, Wang X et al (2021) Interleukin-1\u03b2-treated mesenchymal stem cells inhibit inflammation in hippocampal astrocytes through exosome-activated Nrf-2 signaling. Int J Nanomedicine 16:1423\u20131434","journal-title":"Int J Nanomedicine"},{"key":"6193_CR56","doi-asserted-by":"crossref","unstructured":"Kumar MA, Baba SK, Sadida HQ, Marzooqi SA, Jerobin J, Altemani FH, Algehainy N, Alanazi MA et al (2024) Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct Target Ther 9(1):27","DOI":"10.1038\/s41392-024-01735-1"},{"key":"6193_CR57","doi-asserted-by":"crossref","unstructured":"Cui GH, Wu J, Mou FF, Xie WH, Wang FB, Wang QL, Fang J, Xu YW et al (2018) Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP\/PS1 mice. FASEB J 32(2):654\u2013668","DOI":"10.1096\/fj.201700600R"},{"key":"6193_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1325530","volume":"14","author":"Y Ye","year":"2023","unstructured":"Ye Y, Gao M, Shi W, Gao Y, Li Y, Yang W, Zheng X, Lu X (2023) The immunomodulatory effects of mesenchymal stem cell-derived extracellular vesicles in Alzheimer\u2019s disease. Front Immunol 14:1325530","journal-title":"Front Immunol"},{"issue":"1","key":"6193_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67460-1","volume":"10","author":"M Nakano","year":"2020","unstructured":"Nakano M, Kubota K, Kobayashi E, Chikenji TS, Saito Y, Konari N, Fujimiya M (2020) Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer\u2019s disease model by increasing the expression of microRNA-146a in hippocampus. Sci Rep 10(1):10772","journal-title":"Sci Rep"},{"issue":"5","key":"6193_CR60","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.14336\/AD.2023.1206","volume":"15","author":"W Zhang","year":"2024","unstructured":"Zhang W, Uyemura R, Zhong K, Guo R, Zhong L (2024) Current advances and future perspectives on mesenchymal stem cell-derived extracellular vesicles in Alzheimer\u2019s disease. Aging Dis 15(5):2015\u20132027","journal-title":"Aging Dis"},{"issue":"8","key":"6193_CR61","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","volume":"24","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer\u2019s disease. Neurobiol Aging 24(8):1063\u20131070","journal-title":"Neurobiol Aging"},{"key":"6193_CR62","doi-asserted-by":"crossref","unstructured":"Javonillo DI, Tran KM, Phan J, Hingco E, Kram\u00e1r EA, da Cunha C, Forner S, Kawauchi S, Milinkeviciute G, Gomez-Arboledas A et al (2022) Systematic phenotyping and characterization of the 3xTg-AD mouse model of Alzheimer\u2019s disease. Fronti Neurosci volume 15 - 2021","DOI":"10.3389\/fnins.2021.785276"},{"key":"6193_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113706","volume":"341","author":"AF Neves","year":"2021","unstructured":"Neves AF, Camargo C, Premer C, Hare JM, Baumel BS, Pinto M (2021) Intravenous administration of mesenchymal stem cells reduces tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer\u2019s disease. Exp Neurol 341:113706","journal-title":"Exp Neurol"},{"issue":"6","key":"6193_CR64","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.celrep.2016.06.101","volume":"16","author":"J Jin","year":"2016","unstructured":"Jin J, Kim SN, Liu X, Zhang H, Zhang C, Seo JS, Kim Y, Sun T (2016) MiR-17-92 cluster regulates adult hippocampal neurogenesis, anxiety, and depression. Cell Rep 16(6):1653\u20131663","journal-title":"Cell Rep"},{"key":"6193_CR65","doi-asserted-by":"crossref","unstructured":"Reza-Zaldivar EE, Hern\u00e1ndez-Sapi\u00e9ns MA, Minjarez B, Guti\u00e9rrez-Mercado YK, M\u00e1rquez-Aguirre AL, Canales-Aguirre AA\u00a0(2018) Potential effects of MSC-derived exosomes in neuroplasticity in Alzheimer\u2019s disease. Front Cell Neurosci volume 12","DOI":"10.3389\/fncel.2018.00317"},{"issue":"1","key":"6193_CR66","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-020-00396-2","volume":"15","author":"Z Ruan","year":"2020","unstructured":"Ruan Z, Delpech J-C, Venkatesan Kalavai S, Van Enoo AA, Hu J, Ikezu S, Ikezu T (2020) P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice. Mol Neurodegener 15(1):47","journal-title":"Mol Neurodegener"},{"issue":"1","key":"6193_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01147-4","volume":"10","author":"JP Hulse","year":"2025","unstructured":"Hulse JP, Maphis NM, Peabody J, Bondu V, Chackerian B, Bhaskar K (2025) PS396\/pS404 (PHF1) tau vaccine outperforms pS199\/pS202 (AT8) in rTg4510 tauopathy model. npj Vaccines 10(1):94","journal-title":"npj Vaccines"},{"key":"6193_CR68","doi-asserted-by":"crossref","unstructured":"Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, Wolozin B, Butovsky O et al (2015) Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 18(11):1584\u20131593","DOI":"10.1038\/nn.4132"},{"issue":"1","key":"6193_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0514-4","volume":"6","author":"JC Polanco","year":"2018","unstructured":"Polanco JC, Li C, Durisic N, Sullivan R, G\u00f6tz J (2018) Exosomes taken up by neurons hijack the endosomal pathway to spread to interconnected neurons. Acta Neuropathol Commun 6(1):10","journal-title":"Acta Neuropathol Commun"},{"key":"6193_CR70","doi-asserted-by":"crossref","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q et al (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352(6286):712\u2013716","DOI":"10.1126\/science.aad8373"},{"key":"6193_CR71","doi-asserted-by":"crossref","unstructured":"Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A et al (2017) Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease. Brain 140(12):3286\u20133300","DOI":"10.1093\/brain\/awx243"},{"key":"6193_CR72","doi-asserted-by":"crossref","unstructured":"Frost PS, Barros-Arag\u00e3o F, da Silva RT, Venancio A, Matias I, Lyra e Silva NM, Kincheski GC, Pimentel-Coelho PM et al (2019) Neonatal infection leads to increased susceptibility to A\u03b2 oligomer-induced brain inflammation, synapse loss and cognitive impairment in mice. Cell Death Dis 10(4):323","DOI":"10.1038\/s41419-019-1529-x"},{"issue":"1","key":"6193_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02599-4","volume":"19","author":"X-h Qian","year":"2022","unstructured":"Qian X-h, Liu X-l, Chen G, Chen S-d, Tang H-d (2022) Injection of amyloid-\u03b2 to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer\u2019s disease. J Neuroinflammation 19(1):236","journal-title":"J Neuroinflammation"},{"key":"6193_CR74","doi-asserted-by":"crossref","unstructured":"Micci M-A, Krishnan B, Bishop E, Zhang W-R, Guptarak J, Grant A, Zolochevska O, Tumurbaatar B et al (2019) Hippocampal stem cells promotes synaptic resistance to the dysfunctional impact of amyloid beta oligomers via secreted exosomes. Mol Neurodegener 14(1):25","DOI":"10.1186\/s13024-019-0322-8"},{"issue":"1","key":"6193_CR75","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/brain\/awaa376","volume":"144","author":"Z Ruan","year":"2020","unstructured":"Ruan Z, Pathak D, Venkatesan Kalavai S, Yoshii-Kitahara A, Muraoka S, Bhatt N, Takamatsu-Yukawa K, Hu J, et al. (2020) Alzheimer\u2019s disease brain-derived extracellular vesicles spread tau pathology in interneurons. Brain 144(1):288\u2013309","journal-title":"Brain"},{"key":"6193_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2025.105976","volume":"186","author":"S Xu","year":"2025","unstructured":"Xu S, Liu K, Qian S, Wu J, Hu J, Zhou D, Zheng T (2025) Mechanism of tau protein incorporation into exosomes via cooperative recognition of KFERQ-like motifs by LAMP2A and HSP70. Neurochem Int 186:105976","journal-title":"Neurochem Int"},{"issue":"3","key":"6193_CR77","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.neurobiolaging.2010.03.024","volume":"33","author":"HJ Lee","year":"2012","unstructured":"Lee HJ, Lee JK, Lee H, Carter JE, Chang JW, Oh W, Yang YS, Suh J-G et al (2012) Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer\u2019s disease mouse model through modulation of neuroinflammation. Neurobiol Aging 33(3):588\u2013602","journal-title":"Neurobiol Aging"},{"issue":"1","key":"6193_CR78","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41420-021-00471-7","volume":"7","author":"M Garcia-Contreras","year":"2021","unstructured":"Garcia-Contreras M, Thakor AS (2021) Human adipose tissue-derived mesenchymal stem cells and their extracellular vesicles modulate lipopolysaccharide activated human microglia. Cell Death Discov 7(1):98","journal-title":"Cell Death Discov"},{"issue":"1","key":"6193_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-020-00199-x","volume":"9","author":"C Qin","year":"2020","unstructured":"Qin C, Lu Y, Wang K, Bai L, Shi G, Huang Y, Li Y (2020) Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer\u2019s disease: a meta-analytic review on potential mechanisms. Transl Neurodegener 9(1):20","journal-title":"Transl Neurodegener"},{"key":"6193_CR80","doi-asserted-by":"crossref","unstructured":"Liu Y, Zeng R, Wang Y, Huang W, Hu B, Zhu G, Zhang R, Li F et al (2019) Mesenchymal stem cells enhance microglia M2 polarization and attenuate neuroinflammation through TSG-6. Brain Res 1724:146422","DOI":"10.1016\/j.brainres.2019.146422"},{"issue":"2","key":"6193_CR81","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/stem.277","volume":"28","author":"JK Lee","year":"2010","unstructured":"Lee JK, Jin HK, Endo S, Schuchman EH, Carter JE, Bae JS (2010) Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer\u2019s disease mice by modulation of immune responses. Stem Cells 28(2):329\u2013343","journal-title":"Stem Cells"},{"key":"6193_CR82","doi-asserted-by":"crossref","unstructured":"Yokokawa K, Iwahara N, Hisahara S, Emoto MC, Saito T, Suzuki H, Manabe T, Matsumura A et al (2019) Transplantation of mesenchymal stem cells improves amyloid-\u03b2 pathology by modifying microglial function and suppressing oxidative stress. J Alzheimers Dis 72(3):867\u2013884","DOI":"10.3233\/JAD-190817"},{"key":"6193_CR83","doi-asserted-by":"crossref","unstructured":"Kim HJ, Seo SW, Chang JW, Lee JI, Kim CH, Chin J, Choi SJ, Kwon H et al (2015) Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: a phase 1 clinical trial. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions 1(2):95\u2013102","DOI":"10.1016\/j.trci.2015.06.007"},{"key":"6193_CR84","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7834421","author":"AE Hern\u00e1ndez","year":"2021","unstructured":"Hern\u00e1ndez AE, Garc\u00eda E (2021) Mesenchymal stem cell therapy for Alzheimer\u2019s disease. Stem Cells Int. https:\/\/doi.org\/10.1155\/2021\/7834421","journal-title":"Stem Cells Int"},{"key":"6193_CR85","doi-asserted-by":"crossref","unstructured":"Rash BG, Ramdas KN, Agafonova N, Naioti E, McClain-Moss L, Zainul Z, Varnado B, Peterson K et al (2025) Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer\u2019s disease: a randomized controlled phase 2a trial. Nat Med 31(4):1257\u20131266","DOI":"10.1038\/s41591-025-03559-0"},{"key":"6193_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9060594","author":"YA Chen","year":"2021","unstructured":"Chen YA, Lu CH, Ke CC, Chiu SJ, Jeng FS, Chang CW, Yang BH, Liu RS (2021) Mesenchymal stem cell-derived exosomes ameliorate Alzheimer\u2019s disease pathology and improve cognitive deficits. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9060594","journal-title":"Biomedicines"},{"issue":"2","key":"6193_CR87","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-020-02254-3","volume":"141","author":"JC Polanco","year":"2021","unstructured":"Polanco JC, Hand GR, Briner A, Li C, G\u00f6tz J (2021) Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol. Acta Neuropathol 141(2):235\u2013256","journal-title":"Acta Neuropathol"},{"issue":"1","key":"6193_CR88","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41593-024-01801-5","volume":"28","author":"SL Fowler","year":"2025","unstructured":"Fowler SL, Behr TS, Turkes E, O\u2019Brien DP, Cauhy PM, Rawlinson I, Edmonds M, Foiani MS et al (2025) Tau filaments are tethered within brain extracellular vesicles in Alzheimer\u2019s disease. Nat Neurosci 28(1):40\u201348","journal-title":"Nat Neurosci"},{"key":"6193_CR89","doi-asserted-by":"crossref","unstructured":"Xie X, Song Q, Dai C, Cui S, Tang R, Li S, Chang J, Li P et al (2023) Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer\u2019s disease: a phase I\/II clinical trial. Gen Psychiatry (Lond) 36(5):e101143","DOI":"10.1136\/gpsych-2023-101143"},{"key":"6193_CR90","doi-asserted-by":"crossref","unstructured":"Kim HJ, Seo SW, Chang JW, Lee JI, Kim CH, Chin J, Choi SJ, Kwon H et al (2015) Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: a phase 1 clinical trial. Alzheimers Dement (N Y) 1(2):95\u2013102","DOI":"10.1016\/j.trci.2015.06.007"},{"key":"6193_CR91","doi-asserted-by":"crossref","unstructured":"Choi Y, Shin S, Son HJ, Lee N-H, Myeong SH, Lee C, Jang H, Choi SJ et al (2023) Identification of potential biomarkers related to mesenchymal stem cell response in patients with Alzheimer\u2019s disease. Stem Cell Res Ther 14(1):178","DOI":"10.1186\/s13287-023-03410-8"},{"issue":"3","key":"6193_CR92","doi-asserted-by":"publisher","first-page":"256","DOI":"10.5853\/jos.2016.01263","volume":"18","author":"OY Bang","year":"2016","unstructured":"Bang OY, Kim EH, Cha JM, Moon GJ (2016) Adult stem cell therapy for stroke: challenges and progress. J Stroke 18(3):256\u2013266","journal-title":"J Stroke"},{"key":"6193_CR93","doi-asserted-by":"crossref","unstructured":"Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR, Epple M, Horn PA et al (2014) MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 28(4):970\u2013973","DOI":"10.1038\/leu.2014.41"},{"key":"6193_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13040492","author":"CA Ren\u00e9","year":"2021","unstructured":"Ren\u00e9 CA, Parks RJ (2021) Delivery of therapeutic agents to the central nervous system and the promise of extracellular vesicles. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics13040492","journal-title":"Pharmaceutics"},{"key":"6193_CR95","doi-asserted-by":"crossref","unstructured":"Zhang Z, Zou X, Zhang R, Xie Y, Feng Z, Li F, Han J, Sun H et al (2021) Human umbilical cord mesenchymal stem cell-derived exosomal miR-146a-5p reduces microglial-mediated neuroinflammation via suppression of the IRAK1\/TRAF6 signaling pathway after ischemic stroke. Aging (Albany NY) 13(2):3060\u20133079","DOI":"10.18632\/aging.202466"},{"issue":"1","key":"6193_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00791-2","volume":"10","author":"N Shaheen","year":"2024","unstructured":"Shaheen N, Shaheen A, Osama M, Nashwan AJ, Bharmauria V, Flouty O (2024) MicroRNAs regulation in Parkinson\u2019s disease, and their potential role as diagnostic and therapeutic targets. NPJ Parkinsons Dis 10(1):186","journal-title":"NPJ Parkinsons Dis"},{"key":"6193_CR97","doi-asserted-by":"crossref","unstructured":"Walgrave H, Penning A, Tosoni G, Snoeck S, Davie K, Davis E, Wolfs L, Sierksma A et al (2023) MicroRNA-132 regulates gene expression programs involved in microglial homeostasis. iScience 26(6):106829","DOI":"10.1016\/j.isci.2023.106829"},{"issue":"1","key":"6193_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-02995-w","volume":"13","author":"X Ma","year":"2022","unstructured":"Ma X, Wang Y, Shi Y, Li S, Liu J, Li X, Zhong W, Pan Q (2022) Exosomal miR-132-3p from mesenchymal stromal cells improves synaptic dysfunction and cognitive decline in vascular dementia. Stem Cell Res Ther 13(1):315","journal-title":"Stem Cell Res Ther"},{"key":"6193_CR99","doi-asserted-by":"crossref","unstructured":"Santa-Maria I, Alaniz ME, Renwick N, Cela C, Fulga TA, Van Vactor D, Tuschl T, Clark LN et al (2015) Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. J Clin Invest 125(2):681\u2013686","DOI":"10.1172\/JCI78421"},{"key":"6193_CR100","doi-asserted-by":"crossref","unstructured":"Oh HS, Urey DY, Karlsson L, Zhu Z, Shen Y, Farinas A, Timsina J, Duggan MR et al (2025) A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer\u2019s disease. Nat Med 31(5):1592\u20131603","DOI":"10.1038\/s41591-025-03565-2"},{"issue":"12","key":"6193_CR101","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/s41380-018-0229-8","volume":"23","author":"C Gonzalez","year":"2018","unstructured":"Gonzalez C, Armijo E, Bravo-Alegria J, Becerra-Calixto A, Mays CE, Soto C (2018) Modeling amyloid beta and tau pathology in human cerebral organoids. Mol Psychiatry 23(12):2363\u20132374","journal-title":"Mol Psychiatry"},{"key":"6193_CR102","doi-asserted-by":"publisher","DOI":"10.1242\/dev.166074","author":"X Qian","year":"2019","unstructured":"Qian X, Song H, Ming G-l (2019) Brain organoids: advances, applications and challenges. Development. https:\/\/doi.org\/10.1242\/dev.166074","journal-title":"Development"},{"issue":"1","key":"6193_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-181121","volume":"68","author":"H Hampel","year":"2019","unstructured":"Hampel H, Vergallo A, Perry G, Lista S (2019) The Alzheimer precision medicine initiative. J Alzheimers Dis 68(1):1\u201324","journal-title":"J Alzheimers Dis"},{"key":"6193_CR104","doi-asserted-by":"crossref","unstructured":"Neff RA, Wang M, Vatansever S, Guo L, Ming C, Wang Q, Wang E, Horgusluoglu-Moloch E et al (2021) Molecular subtyping of Alzheimer\u2019s disease using RNA sequencing data reveals novel mechanisms and targets. Sci Adv 7(2):eabb5398","DOI":"10.1126\/sciadv.abb5398"},{"key":"6193_CR105","doi-asserted-by":"publisher","unstructured":"Neff RA, Wang M, Vatansever S, Guo L, Ming C, Wang Q, Wang E, Horgusluoglu-Moloch E et al (2021) Molecular subtyping of Alzheimer\u2019s disease using RNA sequencing data reveals novel mechanisms and targets. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abb5398","DOI":"10.1126\/sciadv.abb5398"},{"key":"6193_CR106","doi-asserted-by":"crossref","unstructured":"Franzmeier N, Dewenter A, Frontzkowski L, Dichgans M, Rubinski A, Neitzel J, Smith R, Strandberg O et al (2020) Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer\u2019s disease. Sci Adv 6(48):eabd1327","DOI":"10.1126\/sciadv.abd1327"},{"key":"6193_CR107","doi-asserted-by":"crossref","unstructured":"Takakura Y, Hanayama R, Akiyoshi K, Futaki S, Hida K, Ichiki T, Ishii-Watabe A, Kuroda M et al (2024) Quality and safety considerations for therapeutic products based on extracellular vesicles. Pharm Res 41(8):1573\u20131594","DOI":"10.1007\/s11095-024-03757-4"},{"issue":"8","key":"6193_CR108","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13904","volume":"17","author":"C-K Wang","year":"2024","unstructured":"Wang C-K, Tsai T-H, Lee C-H (2024) Regulation of exosomes as biologic medicines: regulatory challenges faced in exosome development and manufacturing processes. Clin Transl Sci 17(8):e13904","journal-title":"Clin Transl Sci"},{"key":"6193_CR109","doi-asserted-by":"crossref","unstructured":"Katsuda T, Tsuchiya R, Kosaka N, Yoshioka Y, Takagaki K, Oki K, Takeshita F, Sakai Y et al (2013) Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep 3(1):1197","DOI":"10.1038\/srep01197"},{"issue":"5","key":"6193_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2023.100665","volume":"47","author":"N Tang","year":"2024","unstructured":"Tang N (2024) Exosomes in multiple sclerosis and Alzheimer\u2019s disease \u2013 adversary and ally. Biomed J 47(5):100665","journal-title":"Biomed J"},{"key":"6193_CR111","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.reth.2024.08.001","volume":"26","author":"H-J Liao","year":"2024","unstructured":"Liao H-J, Yang Y-P, Liu Y-H, Tseng H-C, Huo T-I, Chiou S-H, Chang C-H (2024) Harnessing the potential of mesenchymal stem cells\u2013derived exosomes in degenerative diseases. Regen Ther 26:599\u2013610","journal-title":"Regen Ther"},{"issue":"23","key":"6193_CR112","doi-asserted-by":"publisher","first-page":"6626","DOI":"10.1039\/D4TB01530D","volume":"13","author":"X Wen","year":"2025","unstructured":"Wen X, Hao Y (2025) The combined application of exosomes\/exosome-based drug preparations and ultrasound. J Mater Chem B 13(23):6626\u20136637","journal-title":"J Mater Chem B"},{"key":"6193_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114615","volume":"162","author":"A Hazrati","year":"2023","unstructured":"Hazrati A, Mirsanei Z, Heidari N, Malekpour K, Rahmani-Kukia N, Abbasi A, Soudi S (2023) The potential application of encapsulated exosomes: a new approach to increase exosomes therapeutic efficacy. Biomed Pharmacother 162:114615","journal-title":"Biomed Pharmacother"},{"key":"6193_CR114","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.2147\/IJN.S444582","volume":"18","author":"J Tian","year":"2023","unstructured":"Tian J, Han Z, Song D, Peng Y, Xiong M, Chen Z, Duan S, Zhang L (2023) Engineered exosome for drug delivery: recent development and clinical applications. Int J Nanomedicine 18:7923\u20137940","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"6193_CR115","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2017.12","volume":"38","author":"X Luan","year":"2017","unstructured":"Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, Sun D (2017) Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin 38(6):754\u2013763","journal-title":"Acta Pharmacol Sin"},{"key":"6193_CR116","doi-asserted-by":"crossref","unstructured":"Fatima S, Qaiser A, Andleeb S, Hashmi AH, Manzoor S (2024) Navigating the brain: the role of exosomal shuttles in precision therapeutics. Front Neurol\u00a0volume 14 - 2023","DOI":"10.3389\/fneur.2023.1324216"},{"key":"6193_CR117","doi-asserted-by":"crossref","unstructured":"Walker S, Busatto S, Pham A, Tian M, Suh A, Carson K, Quintero A, Lafrence M et al (2019) Extracellular vesicle-based drug delivery systems for cancer treatment. Theranostics 9(26):8001\u20138017","DOI":"10.7150\/thno.37097"},{"key":"6193_CR118","doi-asserted-by":"crossref","unstructured":"Kalimuthu S, Gangadaran P, Rajendran RL, Zhu L, Oh JM, Lee HW, Gopal A, Baek SH, Jeong SY, Lee S-W et al (2018) A new approach for loading anticancer drugs into mesenchymal stem cell-derived exosome mimetics for cancer therapy. Front Pharmacol volume 9","DOI":"10.3389\/fphar.2018.01116"},{"key":"6193_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100760","volume":"22","author":"X Xu","year":"2023","unstructured":"Xu X, Xu L, Wen C, Xia J, Zhang Y, Liang Y (2023) Programming assembly of biomimetic exosomes: an emerging theranostic nanomedicine platform. Mater Today Bio 22:100760","journal-title":"Mater Today Bio"},{"key":"6193_CR120","doi-asserted-by":"crossref","unstructured":"Lopes D, Lopes J, Pereira-Silva M, Peixoto D, Rabiee N, Veiga F, Moradi O, Guo Z-H et al (2023) Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine. Mil Med Res 10(1):19","DOI":"10.1186\/s40779-023-00453-z"},{"issue":"16","key":"6193_CR121","doi-asserted-by":"publisher","first-page":"15189","DOI":"10.1021\/acsnano.5c00700","volume":"19","author":"J Yang","year":"2025","unstructured":"Yang J, des Rieux A, Malfanti A (2025) Stimuli-responsive nanomedicines for the treatment of non-cancer related inflammatory diseases. ACS Nano 19(16):15189\u201315219","journal-title":"ACS Nano"},{"issue":"2","key":"6193_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/ddc4020019","volume":"4","author":"T Premchandani","year":"2025","unstructured":"Premchandani T, Tatode A, Taksande J, Umekar M, Qutub M, Hussain UM, Singanwad P (2025) Engineered exosomes as smart drug carriers: overcoming biological barriers in CNS and cancer therapy. Drugs Drug Candid 4(2):19","journal-title":"Drugs Drug Candid"},{"issue":"1","key":"6193_CR123","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s13287-020-02032-8","volume":"11","author":"ZG Wang","year":"2020","unstructured":"Wang ZG, He ZY, Liang S, Yang Q, Cheng P, Chen AM (2020) Comprehensive proteomic analysis of exosomes derived from human bone marrow, adipose tissue, and umbilical cord mesenchymal stem cells. Stem Cell Res Ther 11(1):511","journal-title":"Stem Cell Res Ther"},{"key":"6193_CR124","doi-asserted-by":"crossref","unstructured":"Hoang DH, Nguyen TD, Nguyen HP, Nguyen XH, Do PTX, Dang VD, Dam PTM, Bui HTH et al (2020) Differential wound healing capacity of mesenchymal stem cell-derived exosomes originated from bone marrow, adipose tissue and umbilical cord under serum- and xeno-free condition. Front Mol Biosci 7:119","DOI":"10.3389\/fmolb.2020.00119"},{"key":"6193_CR125","doi-asserted-by":"crossref","unstructured":"Deng H, Zhu L, Zhang Y, Zheng L, Hu S, Zhou W, Zhang T, Xu W et al (2022) Differential lung protective capacity of exosomes derived from human adipose tissue, bone marrow, and umbilical cord mesenchymal stem cells in sepsis-induced acute lung injury. Oxid Med Cell Longev 2022:7837837","DOI":"10.1155\/2022\/7837837"},{"issue":"1","key":"6193_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01993-z","volume":"9","author":"H Zhang","year":"2024","unstructured":"Zhang H, Xiao X, Wang L, Shi X, Fu N, Wang S, Zhao RC (2024) Human adipose and umbilical cord mesenchymal stem cell-derived extracellular vesicles mitigate photoaging via TIMP1\/Notch1. Signal Transduct Target Ther 9(1):294","journal-title":"Signal Transduct Target Ther"},{"key":"6193_CR127","doi-asserted-by":"crossref","unstructured":"Cone AS, Yuan X, Sun L, Duke LC, Vreones MP, Carrier AN, Kenyon SM, Carver SR et al (2021) Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer\u2019s disease-like phenotypes in a preclinical mouse model. Theranostics 11(17):8129\u20138142","DOI":"10.7150\/thno.62069"},{"key":"6193_CR128","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bbr.2015.07.043","volume":"293","author":"T Mita","year":"2015","unstructured":"Mita T, Furukawa-Hibi Y, Takeuchi H, Hattori H, Yamada K, Hibi H, Ueda M, Yamamoto A (2015) Conditioned medium from the stem cells of human dental pulp improves cognitive function in a mouse model of Alzheimer\u2019s disease. Behav Brain Res 293:189\u2013197","journal-title":"Behav Brain Res"},{"key":"6193_CR129","doi-asserted-by":"crossref","unstructured":"Huang R, Qin C, Wang J, Hu Y, Zheng G, Qiu G, Ge M, Tao H et al (2019) Differential effects of extracellular vesicles from aging and young mesenchymal stem cells in acute lung injury. Aging (Albany NY) 11(18):7996\u20138014","DOI":"10.18632\/aging.102314"},{"issue":"8","key":"6193_CR130","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1007\/s12015-024-10790-8","volume":"20","author":"H Ko\u0161uthov\u00e1","year":"2024","unstructured":"Ko\u0161uthov\u00e1 H, Fecskeov\u00e1 LK, Matejov\u00e1 J, Slovinsk\u00e1 L, Mor\u00e1vek M, B\u00e1rtov\u00e1 Z, Harvanov\u00e1 D (2024) Effects of replicative senescence of human chorionic MSCs on their EV-miRNA profile. Stem Cell Rev Rep 20(8):2318\u20132335","journal-title":"Stem Cell Rev Rep"},{"key":"6193_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060765","author":"M Alicka","year":"2019","unstructured":"Alicka M, Major P, Wysocki M, Marycz K (2019) Adipose-derived mesenchymal stem cells isolated from patients with type 2 diabetes show reduced \u201cstemness\u201d through an altered secretome profile, impaired anti-oxidative protection, and mitochondrial dynamics deterioration. J Clin Med. https:\/\/doi.org\/10.3390\/jcm8060765","journal-title":"J Clin Med"},{"issue":"1","key":"6193_CR132","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13287-024-03722-3","volume":"15","author":"G Maged","year":"2024","unstructured":"Maged G, Abdelsamed MA, Wang H, Lotfy A (2024) The potency of mesenchymal stem\/stromal cells: does donor sex matter? Stem Cell Res Ther 15(1):112","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"6193_CR133","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jcyt.2023.03.008","volume":"25","author":"RJ Madel","year":"2023","unstructured":"Madel RJ, B\u00f6rger V, Dittrich R, Bremer M, Tertel T, Phuong NNT, Baba HA, Kordelas L et al (2023) Independent human mesenchymal stromal cell-derived extracellular vesicle preparations differentially attenuate symptoms in an advanced murine graft-versus-host disease model. Cytotherapy 25(8):821\u2013836","journal-title":"Cytotherapy"},{"issue":"2","key":"6193_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D et al (2024) Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles 13(2):e12404","journal-title":"J Extracell Vesicles"},{"key":"6193_CR135","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jconrel.2020.09.019","volume":"327","author":"X Ma","year":"2020","unstructured":"Ma X, Huang M, Zheng M, Dai C, Song Q, Zhang Q, Li Q, Gu X et al (2020) ADSCs-derived extracellular vesicles alleviate neuronal damage, promote neurogenesis and rescue memory loss in mice with Alzheimer\u2019s disease. J Control Release 327:688\u2013702","journal-title":"J Control Release"},{"issue":"9","key":"6193_CR136","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/sctm.19-0327","volume":"9","author":"M Losurdo","year":"2020","unstructured":"Losurdo M, Pedrazzoli M, D\u2019Agostino C, Elia CA, Massenzio F, Lonati E, Mauri M, Rizzi L et al (2020) Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer\u2019s disease. Stem Cells Transl Med 9(9):1068\u20131084","journal-title":"Stem Cells Transl Med"},{"issue":"8","key":"6193_CR137","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12085","volume":"10","author":"M Kang","year":"2021","unstructured":"Kang M, Jordan V, Blenkiron C, Chamley LW (2021) Biodistribution of extracellular vesicles following administration into animals: a systematic review. J Extracell Vesicles 10(8):e12085","journal-title":"J Extracell Vesicles"},{"key":"6193_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/cells8091059","author":"CA Elia","year":"2019","unstructured":"Elia CA, Tamborini M, Rasile M, Desiato G, Marchetti S, Swuec P, Mazzitelli S, Clemente F et al (2019) Intracerebral injection of extracellular vesicles from mesenchymal stem cells exerts reduced a\u03b2 plaque burden in early stages of a preclinical model of Alzheimer\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/cells8091059","journal-title":"Cells"},{"issue":"3","key":"6193_CR139","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3233\/JAD-170848","volume":"61","author":"SS Wang","year":"2018","unstructured":"Wang SS, Jia J, Wang Z (2018) Mesenchymal stem cell-derived extracellular vesicles suppresses iNOS expression and ameliorates neural impairment in Alzheimer\u2019s disease mice. J Alzheimers Dis 61(3):1005\u20131013","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"6193_CR140","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jcyt.2021.01.001","volume":"23","author":"M Gimona","year":"2021","unstructured":"Gimona M, Brizzi MF, Choo ABH, Dominici M, Davidson SM, Grillari J, Hermann DM, Hill AF et al (2021) Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles. Cytotherapy 23(5):373\u2013380","journal-title":"Cytotherapy"},{"key":"6193_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.101978","volume":"48","author":"K Adlerz","year":"2020","unstructured":"Adlerz K, Patel D, Rowley J, Ng K, Ahsan T (2020) Strategies for scalable manufacturing and translation of MSC-derived extracellular vesicles. Stem Cell Res 48:101978","journal-title":"Stem Cell Res"},{"key":"6193_CR142","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.reth.2024.06.001","volume":"26","author":"Y Shimizu","year":"2024","unstructured":"Shimizu Y, Ntege EH, Inoue Y, Matsuura N, Sunami H, Sowa Y (2024) Optimizing mesenchymal stem cell extracellular vesicles for chronic wound healing: bioengineering, standardization, and safety. Regen Ther 26:260\u2013274","journal-title":"Regen Ther"},{"issue":"1","key":"6193_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25344-6","volume":"12","author":"R Bassil","year":"2021","unstructured":"Bassil R, Shields K, Granger K, Zein I, Ng S, Chih B (2021) Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia. Nat Commun 12(1):5220","journal-title":"Nat Commun"},{"issue":"1","key":"6193_CR144","doi-asserted-by":"publisher","DOI":"10.1186\/s12575-023-00194-2","volume":"25","author":"KL Batenburg","year":"2023","unstructured":"Batenburg KL, Sestito C, Cornelissen-Steijger P, van Weering JRT, Price LS, Heine VM, Scheper W (2023) A 3D human co-culture to model neuron-astrocyte interactions in tauopathies. Biol Proced Online 25(1):4","journal-title":"Biol Proced Online"},{"issue":"3","key":"6193_CR145","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41593-020-00796-z","volume":"24","author":"SR Guttikonda","year":"2021","unstructured":"Guttikonda SR, Sikkema L, Tchieu J, Saurat N, Walsh RM, Harschnitz O, Ciceri G, Sneeboer M et al (2021) Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer\u2019s disease. Nat Neurosci 24(3):343\u2013354","journal-title":"Nat Neurosci"},{"issue":"2","key":"6193_CR146","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/ijms21020665","volume":"21","author":"YW Yi","year":"2020","unstructured":"Yi YW, Lee JH, Kim S-Y, Pack C-G, Ha DH, Park SR, Youn J, Cho BS (2020) Advances in analysis of biodistribution of exosomes by molecular imaging. Int J Mol Sci 21(2):665","journal-title":"Int J Mol Sci"},{"key":"6193_CR147","doi-asserted-by":"crossref","unstructured":"Sperling RA, Jack CR Jr., Aisen PS (2011) Testing the right target and right drug at the right stage. Sci Transl Med 3(111):111cm133","DOI":"10.1126\/scitranslmed.3002609"},{"issue":"6478","key":"6193_CR148","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science 367(6478):eaau6977","journal-title":"Science"},{"key":"6193_CR149","doi-asserted-by":"crossref","unstructured":"Lener T, Gimona M, Aigner L, B\u00f6rger V, Buzas E, Camussi G, Chaput N, Chatterjee D et al (2015) Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles 4:30087","DOI":"10.3402\/jev.v4.30087"},{"issue":"1","key":"6193_CR150","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y (2020) Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol Neurodegener 15(1):40","journal-title":"Mol Neurodegener"},{"key":"6193_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177695","volume":"999","author":"M-A Bashirrohelleh","year":"2025","unstructured":"Bashirrohelleh M-A, Bavarsad K, Khodadadi A, Shohan M, Asadirad A (2025) Curcumin-enhanced stem cell exosomes: a novel approach to modulating neuroinflammation and improving cognitive function in a rat model of Alzheimer\u2019s disease. Eur J Pharmacol 999:177695","journal-title":"Eur J Pharmacol"},{"key":"6193_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151526","volume":"754","author":"R Daksh","year":"2025","unstructured":"Daksh R, Mathew MS, Bosco AM, Sojan C, Tom AA, Bojja SL, Nampoothiri M (2025) The role of exosomes in diagnosis, pathophysiology, and management of Alzheimer\u2019s disease. Biochem Biophys Res Commun 754:151526","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"6193_CR153","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jpedsurg.2018.10.020","volume":"54","author":"SA Tracy","year":"2019","unstructured":"Tracy SA, Ahmed A, Tigges JC, Ericsson M, Pal AK, Zurakowski D, Fauza DO (2019) A comparison of clinically relevant sources of mesenchymal stem cell-derived exosomes: bone marrow and amniotic fluid. J Pediatr Surg 54(1):86\u201390","journal-title":"J Pediatr Surg"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06193-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06193-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06193-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:05:57Z","timestamp":1789027557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06193-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":153,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6193"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06193-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This review synthesizes previously published studies and did not involve new studies with human participants or animals.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D.-H.B. used ChatGPT (OpenAI) and Gemini (Google) as language-support tools during manuscript preparation to assist with organization and clarity. They were not used as sources of scientific authority. All hypotheses, interpretations, references, and conclusions were independently developed and verified by the authors, who take full responsibility for the content of the manuscript.","order":3,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"887"}}